Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Neoplasms of the CNS

Free Subscription Articles published in J Neurosurg Retrieve available abstracts of 201 articles: HTML format

Single Articles

March 2023
1. ZHAO B, Ma W
   Letter to the Editor. Acoustic analysis during glioma surgery.
   J Neurosurg. 2023 Mar 3:1. doi: 10.3171/2023.1.JNS2395.
   PubMed    
   
   
   
2. TRAYLOR JI, Plitt AR, Hicks WH, Mian TM, et al
   Evaluating risk of recurrence in patients with meningioma.
   J Neurosurg. 2022;138:621-628.
   PubMed     Abstract available
   
   
   
3. YAN M, Holden L, Detsky J, Tseng CL, et al
   Conventionally fully fractionated Gamma Knife Icon re-irradiation of primary recurrent intracranial tumors: the first report indicating feasibility and safety.
   J Neurosurg. 2022;138:674-682.
   PubMed     Abstract available
   
   
   February 2023
4. SCHUPPER AJ, Hadjipanayis CG
   Novel approaches to targeting gliomas at the leading/cutting edge.
   J Neurosurg. 2023 Feb 24:1-9. doi: 10.3171/2023.1.JNS221798.
   PubMed     Abstract available
   
   
   
5. EL-SHEHABY AMN, Reda WA, Abdel Karim KM, Nabeel AM, et al
   Single-session stereotactic radiosurgery for large perioptic meningiomas.
   J Neurosurg. 2023 Feb 17:1-10. doi: 10.3171/2023.1.JNS221951.
   PubMed     Abstract available
   
   
   
6. YOUNG JS, Al-Adli N, Scotford K, Cha S, et al
   Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know.
   J Neurosurg. 2023 Feb 10:1-12. doi: 10.3171/2022.12.JNS222173.
   PubMed     Abstract available
   
   
   
7. LOPEZ DC, Almeida JP, Momin AA, Andrade EJ, et al
   Triphasic response after endoscopic craniopharyngioma resection and its dependency on infundibular preservation or sacrifice.
   J Neurosurg. 2023 Feb 3:1-8. doi: 10.3171/2022.12.JNS221137.
   PubMed     Abstract available
   
   
   
8. RUBINO F, Schur S, McGovern SL, Kamiya-Matsuoka C, et al
   Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
   J Neurosurg. 2023 Feb 3:1-12. doi: 10.3171/2022.12.JNS222010.
   PubMed     Abstract available
   
   
   
9. BIANCO A, Del Maestro M, Fanti A, Airoldi C, et al
   Use of fluorescein sodium-assisted intraoperative sample validation to maximize the diagnostic yield of stereotactic brain biopsy: progress toward a new standard of care?
   J Neurosurg. 2022;138:358-366.
   PubMed     Abstract available
   
   
   
10. CASTLE-KIRSZBAUM M, Wang YY, King J, Kam J, et al
    Quality of life and surgical outcomes in incidental pituitary adenomas undergoing endoscopic endonasal resection.
    J Neurosurg. 2022;138:567-573.
    PubMed     Abstract available
    
    
    January 2023
11. IWAHASHI H, Nagashima H, Tanaka K, Uno T, et al
    2-Hydroxyglutarate magnetic resonance spectroscopy in adult brainstem glioma.
    J Neurosurg. 2023 Jan 27:1-8. doi: 10.3171/2022.12.JNS221954.
    PubMed     Abstract available
    
    
    
12. PRZYBYLOWSKI CJ, Suki D, Raza SM, DeMonte F, et al
    Volumetric extent of resection and survival for recurrent atypical meningioma.
    J Neurosurg. 2023 Jan 27:1-11. doi: 10.3171/2022.12.JNS221815.
    PubMed     Abstract available
    
    
    
13. MURAGAKI Y, Ishikawa E, Maruyama T, Nitta M, et al
    A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomas.
    J Neurosurg. 2023 Jan 20:1-11. doi: 10.3171/2022.12.JNS221221.
    PubMed     Abstract available
    
    
    
14. MORSHED RA, Saggi S, Cummins DD, Molinaro AM, et al
    Identification of risk factors associated with leptomeningeal disease after resection of brain metastases.
    J Neurosurg. 2023 Jan 13:1-12. doi: 10.3171/2022.12.JNS221490.
    PubMed     Abstract available
    
    
    
15. GIAMMATTEI L, Passeri T, Abbritti R, Lieber S, et al
    Surgical morbidity of the extradural anterior petrosal approach: the Lariboisiere experience.
    J Neurosurg. 2022;138:276-286.
    PubMed     Abstract available
    
    
    
16. ICHIMASU N, Kohno M, Nakajima N, Sakamoto H, et al
    Features of postoperative hearing function changes in patients with cerebellopontine angle and intratemporal tumors other than vestibular schwannomas.
    J Neurosurg. 2022;138:78-85.
    PubMed     Abstract available
    
    
    December 2022
17. CATALINO MP, Buss E, Chamberlin G, Trembath D, et al
    Tumor sound, auditory cues, and tissue pathology in glioma surgery: a proof-of-concept study.
    J Neurosurg. 2022 Dec 30:1-9. doi: 10.3171/2022.11.JNS222114.
    PubMed     Abstract available
    
    
    
18. HERTA J, Cho A, Roetzer-Pejrimovsky T, Hoftberger R, et al
    Optimizing maximum resection of glioblastoma: Raman spectroscopy versus 5-aminolevulinic acid.
    J Neurosurg. 2022 Dec 23:1-10. doi: 10.3171/2022.11.JNS22693.
    PubMed     Abstract available
    
    
    
19. LV K, Chen H, Cao X, Du P, et al
    Development and validation of a machine learning algorithm for predicting diffuse midline glioma, H3 K27-altered, H3 K27 wild-type high-grade glioma, and primary CNS lymphoma of the brain midline in adults.
    J Neurosurg. 2022 Dec 23:1-9. doi: 10.3171/2022.11.JNS221544.
    PubMed     Abstract available
    
    
    
20. CHIANG CL, Yang HC, Luo YH, Chen CJ, et al
    Leptomeningeal metastasis in patients with non-small cell lung cancer after stereotactic radiosurgery for brain metastasis.
    J Neurosurg. 2022 Dec 9:1-8. doi: 10.3171/2022.11.JNS221888.
    PubMed     Abstract available
    
    
    
21. SHASBY G
    Erratum. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    J Neurosurg. 2022 Dec 9:1. doi: 10.3171/2022.11.JNS192155.
    PubMed    
    
    
    
22. ZHONG S, Ren JX, Yu ZP, Peng YD, et al
    Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics.
    J Neurosurg. 2022 Dec 2:1-10. doi: 10.3171/2022.10.JNS22801.
    PubMed     Abstract available
    
    
    
23. YUAN Q, Yao HJ, Xi CH, Yu C, et al
    Perioperative risk factors associated with unplanned neurological intensive care unit readmission following elective supratentorial brain tumor resection.
    J Neurosurg. 2022 Dec 2:1-9. doi: 10.3171/2022.10.JNS221318.
    PubMed     Abstract available
    
    
    
24. TUNCER MS, Fekonja LS, Ott S, Pfnur A, et al
    Role of interhemispheric connectivity in recovery from postoperative supplementary motor area syndrome in glioma patients.
    J Neurosurg. 2022 Dec 2:1-10. doi: 10.3171/2022.10.JNS221303.
    PubMed     Abstract available
    
    
    
25. CHALIF EJ, Morshed RA, Young JS, Haddad AF, et al
    Pituitary adenoma in the elderly: surgical outcomes and treatment trends in the United States.
    J Neurosurg. 2022;137:1687-1698.
    PubMed     Abstract available
    
    
    
26. DASHTI SR, Kadner RJ, Folley BS, Sheehan JP, et al
    Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
    J Neurosurg. 2022;137:1676-1686.
    PubMed     Abstract available
    
    
    
27. COTE DJ, Ruzevick JJ, Kang KM, Pangal DJ, et al
    Association between socioeconomic status and presenting characteristics and extent of disease in patients with surgically resected nonfunctioning pituitary adenoma.
    J Neurosurg. 2022;137:1699-1706.
    PubMed     Abstract available
    
    
    November 2022
28. KOWALCHUK RO, Niranjan A, Hess J, Antonios JP, et al
    Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer.
    J Neurosurg. 2022 Nov 25:1-7. doi: 10.3171/2022.10.JNS221900.
    PubMed     Abstract available
    
    
    
29. QUINONES A, Jenabi M, Pasquini L, Peck KK, et al
    Use of longitudinal functional MRI to demonstrate translocation of language function in patients with brain tumors.
    J Neurosurg. 2022 Nov 25:1-9. doi: 10.3171/2022.10.JNS221212.
    PubMed     Abstract available
    
    
    
30. SASAKI T, Watanabe J, He X, Katagi H, et al
    Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma.
    J Neurosurg. 2022 Nov 11:1-10. doi: 10.3171/2022.9.JNS22715.
    PubMed     Abstract available
    
    
    
31. KOFOED LAURIDSEN E, Ciochon UM, Tolver A, Bech Knudsen M, et al
    Long-term postoperative health-related quality of life in patients with subfrontal meningiomas.
    J Neurosurg. 2022 Nov 11:1-10. doi: 10.3171/2022.9.JNS22826.
    PubMed     Abstract available
    
    
    
32. DOHM AE, Tang JD, Mills MN, Liveringhouse CL, et al
    Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone.
    J Neurosurg. 2022 Nov 11:1-8. doi: 10.3171/2022.9.JNS221896.
    PubMed     Abstract available
    
    
    
33. SUN GC, Shu XJ, Zheng XQ, Ma XD, et al
    The transfrontal isthmus approach for insular glioma surgery.
    J Neurosurg. 2022 Nov 11:1-9. doi: 10.3171/2022.8.JNS22923.
    PubMed     Abstract available
    
    
    
34. PARK YW, Han K, Park JE, Ahn SS, et al
    Leptomeningeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging.
    J Neurosurg. 2022 Nov 4:1-11. doi: 10.3171/2022.9.JNS221659.
    PubMed     Abstract available
    
    
    
35. HAJTOVIC S, Sun J, Multani JS, Herrmann LL, et al
    Surgical cytoreduction of deep-seated high-grade glioma through tubular retractor.
    J Neurosurg. 2022 Nov 4:1-12. doi: 10.3171/2022.9.JNS22842.
    PubMed     Abstract available
    
    
    
36. REN L, Cheng H, Chen J, Deng J, et al
    Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.
    J Neurosurg. 2022 Nov 4:1-10. doi: 10.3171/2022.9.JNS221530.
    PubMed     Abstract available
    
    
    
37. YOUNG JS, Al-Adli N, Sibih YE, Scotford KL, et al
    Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a systematic review of what neurosurgeons need to know.
    J Neurosurg. 2022 Nov 4:1-9. doi: 10.3171/2022.9.JNS221139.
    PubMed     Abstract available
    
    
    October 2022
38. DIJKSTRA BM, Nonnekens J, Nagengast W, Kruijff S, et al
    Feasibility of bevacizumab-IRDye800CW as a tracer for fluorescence-guided meningioma surgery.
    J Neurosurg. 2022 Oct 28:1-10. doi: 10.3171/2022.9.JNS221036.
    PubMed     Abstract available
    
    
    
39. YOMO S, Oda K, Oguchi K
    Effectiveness of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with brain metastases from renal cell carcinoma: inverse probability of treatment weighting using propensity scores.
    J Neurosurg. 2022 Oct 28:1-9. doi: 10.3171/2022.9.JNS221215.
    PubMed     Abstract available
    
    
    
40. RIBEIRO L, Ng S, Duffau H
    Recurrent insular low-grade gliomas: factors guiding the decision to reoperate.
    J Neurosurg. 2022 Oct 28:1-11. doi: 10.3171/2022.9.JNS221286.
    PubMed     Abstract available
    
    
    
41. ZHANG Y, Tan H, Jia L, He J, et al
    Association of preoperative glucose concentration with mortality in patients undergoing craniotomy for brain tumor.
    J Neurosurg. 2022 Oct 28:1-9. doi: 10.3171/2022.9.JNS221251.
    PubMed     Abstract available
    
    
    
42. NG S, Deverdun J, Lemaitre AL, Giampiccolo D, et al
    Precuneal gliomas promote behaviorally relevant remodeling of the functional connectome.
    J Neurosurg. 2022 Oct 28:1-11. doi: 10.3171/2022.9.JNS221723.
    PubMed     Abstract available
    
    
    
43. TEWARIE IA, Senko AW, Jessurun CAC, Zhang AT, et al
    Predicting leptomeningeal disease spread after resection of brain metastases using machine learning.
    J Neurosurg. 2022 Oct 21:1-9. doi: 10.3171/2022.8.JNS22744.
    PubMed     Abstract available
    
    
    
44. LAIGLE-DONADEY F, Metellus P, Guyotat J, Menei P, et al
    Surgery for glioblastomas in the elderly: an Association des Neuro-oncologues d'Expression Francaise (ANOCEF) trial.
    J Neurosurg. 2022 Oct 14:1-7. doi: 10.3171/2022.8.JNS221068.
    PubMed     Abstract available
    
    
    
45. ZHANG X, Zhang G, Wang Y, Huang H, et al
    Alteration of default mode network: association with executive dysfunction in frontal glioma patients.
    J Neurosurg. 2022 Oct 14:1-10. doi: 10.3171/2022.8.JNS22591.
    PubMed     Abstract available
    
    
    
46. ZHANG JJY, Lee KS, Wang DD, Hervey-Jumper SL, et al
    Seizure outcome after resection of insular glioma: a systematic review, meta-analysis, and institutional experience.
    J Neurosurg. 2022 Oct 14:1-12. doi: 10.3171/2022.8.JNS221067.
    PubMed     Abstract available
    
    
    
47. TROUDE L, Avinens V, Farah K, Boucekine M, et al
    Surgical management of large cerebellopontine angle meningiomas: long-term results of a less aggressive resection strategy.
    J Neurosurg. 2022 Oct 7:1-10. doi: 10.3171/2022.8.JNS221329.
    PubMed     Abstract available
    
    
    
48. LEE EJ, Chung HT, Park H, Kim JW, et al
    Factors associated with radiation toxicity and long-term tumor control more than 10 years after Gamma Knife surgery for non-skull base, nonperioptic benign supratentorial meningiomas.
    J Neurosurg. 2022 Oct 7:1-11. doi: 10.3171/2022.8.JNS22422.
    PubMed     Abstract available
    
    
    
49. NAIR SK, Botros D, Chakravarti S, Mao Y, et al
    Predictors of surgical site infection in glioblastoma patients undergoing craniotomy for tumor resection.
    J Neurosurg. 2022 Oct 7:1-8. doi: 10.3171/2022.8.JNS212799.
    PubMed     Abstract available
    
    
    September 2022
50. HENDERSON F, Youngerman BE, Niogi SN, Alexander T, et al
    Endonasal transsphenoidal surgery for planum sphenoidale versus tuberculum sellae meningiomas.
    J Neurosurg. 2022 Sep 30:1-9. doi: 10.3171/2022.8.JNS22632.
    PubMed     Abstract available
    
    
    
51. CHEN CH, Wei KC, Liao WC, Lin YY, et al
    Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan.
    J Neurosurg. 2022 Sep 23:1-13. doi: 10.3171/2022.7.JNS2250.
    PubMed     Abstract available
    
    
    
52. YAMADA S, Hirayama R, Iwata T, Kuroda H, et al
    Growth risk classification and typical growth speed of convexity, parasagittal, and falx meningiomas: a retrospective cohort study.
    J Neurosurg. 2022 Sep 16:1-7. doi: 10.3171/2022.8.JNS221290.
    PubMed     Abstract available
    
    
    
53. HOSMANN A, Jaber M, Roetzer-Pejrimovsky T, Timelthaler G, et al
    CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers.
    J Neurosurg. 2022 Sep 16:1-10. doi: 10.3171/2022.7.JNS22921.
    PubMed     Abstract available
    
    
    
54. MAIER AD, Meddis A, Mirian C, Haslund-Vinding J, et al
    Gene expression analysis during progression of malignant meningioma compared to benign meningioma.
    J Neurosurg. 2022 Sep 16:1-11. doi: 10.3171/2022.7.JNS22585.
    PubMed     Abstract available
    
    
    
55. LEHRER EJ, Ahluwalia MS, Gurewitz J, Bernstein K, et al
    Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697
    J Neurosurg. 2022 Sep 16:1-10. doi: 10.3171/2022.7.JNS22752.
    PubMed     Abstract available
    
    
    
56. ZHAO B, Xing H, Xia Y, Ma W, et al
    Letter to the Editor. Supramaximal resection for newly diagnosed eloquent glioblastoma.
    J Neurosurg. 2022 Sep 16:1-2. doi: 10.3171/2022.6.JNS221338.
    PubMed    
    
    
    
57. HANNA GK, Madany M, Tay ASS, Edwards LA, et al
    ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiation.
    J Neurosurg. 2022 Sep 16:1-12. doi: 10.3171/2022.7.JNS22259.
    PubMed     Abstract available
    
    
    
58. HIMES BT, Fain CE, Tritz ZP, Nesvick CL, et al
    Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles.
    J Neurosurg. 2022 Sep 16:1-11. doi: 10.3171/2022.6.JNS2274.
    PubMed     Abstract available
    
    
    August 2022
59. PEREIRA BJA, Marcondes Lerario A, Sola PR, Laurentino TS, et al
    Impact of a cell cycle and an extracellular matrix remodeling transcriptional signature on tumor progression and correlation with EZH2 expression in meningioma.
    J Neurosurg. 2022 Aug 26:1-14. doi: 10.3171/2022.7.JNS22953.
    PubMed     Abstract available
    
    
    
60. PARK J, Sim J, Ahn J, Kim YJ, et al
    Molecular characteristics of incidental lower-grade glioma for treatment decision-making.
    J Neurosurg. 2022 Aug 19:1-10. doi: 10.3171/2022.6.JNS22967.
    PubMed     Abstract available
    
    
    
61. ROH H, Lee SY, Lee J, Hwang SY, et al
    Use of thyroid transcription factor 1 and napsin A to predict local failure and survival after Gamma Knife radiosurgery in patients with brain metastases from lung adenocarcinoma.
    J Neurosurg. 2022 Aug 12:1-11. doi: 10.3171/2022.6.JNS22450.
    PubMed     Abstract available
    
    
    
62. WANG Y, Sakaguchi M, Sabit H, Tamai S, et al
    COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion.
    J Neurosurg. 2022 Aug 5:1-10. doi: 10.3171/2022.6.JNS22319.
    PubMed     Abstract available
    
    
    July 2022
63. GAO S, Jin L, Moliterno J, Corbin ZA, et al
    Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.
    J Neurosurg. 2022 Jul 29:1-11. doi: 10.3171/2022.5.JNS212761.
    PubMed     Abstract available
    
    
    
64. KIM YJ, Moon KS, Jang WY, Jung TY, et al
    Contralateral subfrontal approach for tuberculum sellae meningioma: techniques and clinical outcomes.
    J Neurosurg. 2022 Jul 22:1-12. doi: 10.3171/2022.5.JNS212899.
    PubMed     Abstract available
    
    
    
65. PITSKHELAURI D, Sufianov R, Konovalov A, Pronin I, et al
    Median trans-atlanto-occipital membrane microsurgical approach to the posterior cranial fossa without craniotomy.
    J Neurosurg. 2022 Jul 22:1-8. doi: 10.3171/2022.5.JNS22111.
    PubMed     Abstract available
    
    
    
66. SOLARI D, d'Avella E, Agresta G, Catapano D, et al
    Endoscopic endonasal approach for infradiaphragmatic craniopharyngiomas: a multicentric Italian study.
    J Neurosurg. 2022 Jul 8:1-11. doi: 10.3171/2022.5.JNS212974.
    PubMed     Abstract available
    
    
    
67. ABRAMOV I, Park MT, Belykh E, Dru AB, et al
    Intraoperative confocal laser endomicroscopy: prospective in vivo feasibility study of a clinical-grade system for brain tumors.
    J Neurosurg. 2022 Jul 8:1-11. doi: 10.3171/2022.5.JNS2282.
    PubMed     Abstract available
    
    
    June 2022
68. YU ZY, Chung MH, Wang PW, Wu YC, et al
    Letter to the Editor. Prediction model of IDH wild-type glioblastoma.
    J Neurosurg. 2022;137:1200.
    PubMed    
    
    
    
69. NGUYEN MP, Morshed RA, Dalle Ore CL, Cummins DD, et al
    Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma.
    J Neurosurg. 2022 Jun 3:1-9. doi: 10.3171/2022.4.JNS212516.
    PubMed     Abstract available
    
    
    May 2022
70. CHOTAI S, Tang AR, McDermott JR, Guidry BS, et al
    Comparison of supratentorial meningioma resection outcomes by dural reconstruction technique.
    J Neurosurg. 2022 May 27:1-8. doi: 10.3171/2022.4.JNS22290.
    PubMed     Abstract available
    
    
    
71. YU ZY, Chung MH, Wang PW, Wu YC, et al
    Letter to the Editor. Outcome of malignant meningioma.
    J Neurosurg. 2022 May 27:1. doi: 10.3171/2022.3.JNS22645.
    PubMed    
    
    
    
72. NICHOLS NM, Hadjipanayis CG
    Editorial. Supramaximal resection of eloquent glioblastoma: a continued paradigm shift in neurosurgical oncology.
    J Neurosurg. 2022 May 27:1-3. doi: 10.3171/2022.3.JNS22564.
    PubMed    
    
    
    
73. DI L, Shah AH, Mahavadi A, Eichberg DG, et al
    Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
    J Neurosurg. 2022 May 27:1-8. doi: 10.3171/2022.3.JNS212399.
    PubMed     Abstract available
    
    
    
74. HASEGAWA H, Inoue A, Helal A, Kashiwabara K, et al
    Pineal cyst: results of long-term MRI surveillance and analysis of growth and shrinkage rates.
    J Neurosurg. 2022 May 27:1-7. doi: 10.3171/2022.4.JNS22276.
    PubMed     Abstract available
    
    
    
75. SNEED PK, Chan JW, Ma L, Braunstein SE, et al
    Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
    J Neurosurg. 2022 May 20:1-9. doi: 10.3171/2022.4.JNS212597.
    PubMed     Abstract available
    
    
    
76. TANJI M, Mineharu Y, Sakata A, Okuchi S, et al
    High intratumoral susceptibility signal grade on susceptibility-weighted imaging: a risk factor for hemorrhage after stereotactic biopsy.
    J Neurosurg. 2022 May 13:1-8. doi: 10.3171/2022.4.JNS212505.
    PubMed     Abstract available
    
    
    April 2022
77. BETTAG C, Hussein A, Schatlo B, Barrantes-Freer A, et al
    Endoscope-assisted visualization of 5-aminolevulinic acid fluorescence in surgery for brain metastases.
    J Neurosurg. 2022 Apr 29:1-6. doi: 10.3171/2022.3.JNS212301.
    PubMed     Abstract available
    
    
    
78. GARCIA JH, Morshed RA, Chung J, Millares Chavez MA, et al
    Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases.
    J Neurosurg. 2022 Apr 29:1-8. doi: 10.3171/2022.3.JNS212285.
    PubMed     Abstract available
    
    
    
79. THOMANN P, Hani L, Vulcu S, Schutz A, et al
    Natural history of meningiomas: a serial volumetric analysis of 240 tumors.
    J Neurosurg. 2022 Apr 29:1-11. doi: 10.3171/2022.3.JNS212626.
    PubMed     Abstract available
    
    
    
80. LARKIN CJ, Yerneni K, Karras CL, Abecassis ZA, et al
    Impact of intraoperative direct cortical stimulation dynamics on perioperative seizures and afterdischarge frequency in patients undergoing awake craniotomy.
    J Neurosurg. 2022 Apr 29:1-9. doi: 10.3171/2022.
    PubMed     Abstract available
    
    
    
81. PARK HH, Yoo J, Oh HC, Cha YJ, et al
    Regrowth factors of WHO grade I skull base meningiomas following incomplete resection.
    J Neurosurg. 2022 Apr 22:1-10. doi: 10.3171/2022.3.JNS2299.
    PubMed     Abstract available
    
    
    
82. CHO A, Medvedeva K, Kranawetter B, Untersteiner H, et al
    How to dose-stage large or high-risk brain metastases: an alternative two-fraction radiosurgical treatment approach.
    J Neurosurg. 2022 Apr 15:1-10. doi: 10.3171/2022.2.JNS212440.
    PubMed     Abstract available
    
    
    
83. WANG Y, Pan C, Xie M, Zuo P, et al
    Adult diffuse intrinsic pontine glioma: clinical, radiological, pathological, molecular features, and treatments of 96 patients.
    J Neurosurg. 2022 Apr 8:1-11. doi: 10.3171/2022.2.JNS211920.
    PubMed     Abstract available
    
    
    
84. KIM AA, Dono A, Khalafallah AM, Nettel-Rueda B, et al
    Early repeat resection for residual glioblastoma: decision-making among an international cohort of neurosurgeons.
    J Neurosurg. 2022 Apr 1:1-10. doi: 10.3171/2022.1.JNS211970.
    PubMed     Abstract available
    
    
    
85. GOEL A, Shah A, Vutha R
    Letter to the Editor. En masse resection of gliomas.
    J Neurosurg. 2022 Apr 1:1-2. doi: 10.3171/2022.1.JNS22107.
    PubMed    
    
    
    
86. CASTRO MRH, Magill ST, Morshed RA, Young JS, et al
    Facial pain and sensory outcomes following resection of tumors compressing the trigeminal nerve.
    J Neurosurg. 2021;136:1119-1127.
    PubMed     Abstract available
    
    
    
87. KINOSHITA Y, Zomorodi AR, Friedman AH, Sato H, et al
    Retrolabyrinthine transsigmoid approach to complex parabrainstem tumors in the posterior fossa.
    J Neurosurg. 2021;136:1097-1102.
    PubMed     Abstract available
    
    
    
88. HUNDLEY KN, Pait TG, Rodriguez A, Day JD, et al
    Dr. Louise Eisenhardt's personal notes: how she and Dr. Cushing collected data and followed patients.
    J Neurosurg. 2021;136:1173-1178.
    PubMed     Abstract available
    
    
    
89. ROSENSTOCK T, Hani L, Grittner U, Schlinkmann N, et al
    Bicentric validation of the navigated transcranial magnetic stimulation motor risk stratification model.
    J Neurosurg. 2021;136:1194-1206.
    PubMed     Abstract available
    
    
    March 2022
90. STRICKLAND BA, Wedemeyer M, Ruzevick J, Micko A, et al
    5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
    J Neurosurg. 2022 Mar 18:1-9. doi: 10.3171/2022.1.JNS212562.
    PubMed     Abstract available
    
    
    
91. KIM KM, Kim SM, Kang H, Ji SY, et al
    Preservation of language function by mapping the arcuate fasciculus using intraoperative corticocortical evoked potential under general anesthesia in glioma surgery.
    J Neurosurg. 2022 Mar 18:1-9. doi: 10.3171/2022.1.JNS212658.
    PubMed     Abstract available
    
    
    
92. DE SWART ME, Muller DMJ, Ardon H, Balvers RK, et al
    Between-hospital variation in time to glioblastoma surgery: a report from the Quality Registry Neuro Surgery in the Netherlands.
    J Neurosurg. 2022 Mar 11:1-10. doi: 10.3171/2022.1.JNS212566.
    PubMed     Abstract available
    
    
    
93. MAIER AD, Mirian C, Haslund-Vinding J, Bartek J, et al
    Granular clinical history and outcome in 51 patients with primary and secondary malignant meningioma.
    J Neurosurg. 2022 Mar 11:1-11. doi: 10.3171/2022.1.JNS212723.
    PubMed     Abstract available
    
    
    
94. JIMENEZ AE, Cicalese KV, Chakravarti S, Porras JL, et al
    Social determinants of health and the prediction of 90-day mortality among brain tumor patients.
    J Neurosurg. 2022 Mar 11:1-9. doi: 10.3171/2022.1.JNS212829.
    PubMed     Abstract available
    
    
    
95. JAKOLA AS, Pedersen LK, Skjulsvik AJ, Myrmel K, et al
    The impact of resection in IDH-mutant WHO grade 2 gliomas: a retrospective population-based parallel cohort study.
    J Neurosurg. 2022 Mar 4:1-8. doi: 10.3171/2022.1.JNS212514.
    PubMed     Abstract available
    
    
    
96. MRAH S, Descoteaux M, Wager M, Bore A, et al
    Network-level prediction of set-shifting deterioration after lower-grade glioma resection.
    J Neurosurg. 2022 Mar 4:1-9. doi: 10.3171/2022.1.JNS212257.
    PubMed     Abstract available
    
    
    
97. POMERANIEC IJ, Xu Z, Lee CC, Yang HC, et al
    Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
    J Neurosurg. 2021;136:813-821.
    PubMed     Abstract available
    
    
    
98. CEYLAN S, Sen HE, Ozsoy B, Ceylan EC, et al
    Endoscopic approach for giant pituitary adenoma: clinical outcomes of 205 patients and comparison of two proposed classification systems for preoperative prediction of extent of resection.
    J Neurosurg. 2021;136:786-800.
    PubMed     Abstract available
    
    
    
99. LABIB MA, Zhao X, Houlihan LM, Abramov I, et al
    Comparative analysis of the combined petrosal and the pretemporal transcavernous anterior petrosal approach to the petroclival region.
    J Neurosurg. 2021;136:905-916.
    PubMed     Abstract available
    
    
    
100. RICHE M, Marijon P, Amelot A, Bielle F, et al
     Severity, timeline, and management of complications after stereotactic brain biopsy.
     J Neurosurg. 2021;136:867-876.
     PubMed     Abstract available
     
     
     
101. MATHIEU D, Kotecha R, Sahgal A, De Salles A, et al
     Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations.
     J Neurosurg. 2021;136:801-812.
     PubMed     Abstract available
     
     
     February 2022
102. SUERO MOLINA E, Black D, Kaneko S, Muther M, et al
     Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma.
     J Neurosurg. 2022 Feb 25:1-10. doi: 10.3171/2021.12.JNS211724.
     PubMed     Abstract available
     
     
     
103. MATSUNAGA S, Shuto T, Serizawa T, Aoyagi K, et al
     Gamma Knife radiosurgery for metastatic brain tumors from ovarian cancer: histopathological analysis of survival and local control. A Japanese multi-institutional cooperative and retrospective cohort study.
     J Neurosurg. 2022 Feb 11:1-9. doi: 10.3171/2021.12.JNS212239.
     PubMed     Abstract available
     
     
     
104. CHO A, Hennenberg J, Untersteiner H, Hirschmann D, et al
     Influence of temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non-small cell lung cancer.
     J Neurosurg. 2022 Feb 4:1-7. doi: 10.3171/2021.12.JNS212193.
     PubMed     Abstract available
     
     
     
105. LEE WJ, Hong SD, Woo KI, Seol HJ, et al
     Endoscopic endonasal and transorbital approaches to petrous apex lesions.
     J Neurosurg. 2021;136:431-440.
     PubMed     Abstract available
     
     
     
106. TOMIO R, Horiguchi T, Borghei-Razavi H, Tamura R, et al
     Anterior transpetrosal approach: experiences in 274 cases over 33 years. Technical variations, operated patients, and approach-related complications.
     J Neurosurg. 2021;136:413-421.
     PubMed     Abstract available
     
     
     
107. ZHANG JJ, Liu YH, Tu MY, Wei K, et al
     Comparison of 1.0 g/kg of 20% mannitol initiated at different time points and effects on brain relaxation in patients with midline shift undergoing supratentorial tumor resection: a randomized controlled trial.
     J Neurosurg. 2021;136:350-357.
     PubMed     Abstract available
     
     
     
108. ASHER AL, Khalafallah AM, Mukherjee D, Alvi MA, et al
     Launching the Quality Outcomes Database Tumor Registry: rationale, development, and pilot data.
     J Neurosurg. 2021;136:369-378.
     PubMed     Abstract available
     
     
     
109. HARDESTY DA, Montaser A, Kreatsoulas D, Shah VS, et al
     Complications after 1002 endoscopic endonasal approach procedures at a single center: lessons learned, 2010-2018.
     J Neurosurg. 2021;136:393-404.
     PubMed     Abstract available
     
     
     
110. SNYDER MH, Asuzu DT, Shaver DE, Vance ML, et al
     Routine postoperative fluid restriction to prevent syndrome of inappropriate antidiuretic hormone secretion after transsphenoidal resection of pituitary adenoma.
     J Neurosurg. 2021;136:405-412.
     PubMed     Abstract available
     
     
     January 2022
111. CHEN WC, Lafreniere M, Phuong C, Liu SJ, et al
     Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
     J Neurosurg. 2022 Jan 21:1-7. doi: 10.3171/2021.10.JNS211886.
     PubMed     Abstract available
     
     
     
112. MATHIESEN T, Haslund-Vinding J, Skjoth-Rasmussen J, Poulsgaard L, et al
     Letter to the Editor. Copenhagen grading of meningioma.
     J Neurosurg. 2022 Jan 21:1-3. doi: 10.3171/2021.10.JNS204467.
     PubMed    
     
     
     
113. CASTLE-KIRSZBAUM M, Kam J, Dixon B, Goldschlager T, et al
     Surgical outcomes and longitudinal quality of life after endoscopic endonasal surgery for anterior skull base meningioma.
     J Neurosurg. 2022 Jan 14:1-8. doi: 10.3171/2021.11.JNS212090.
     PubMed     Abstract available
     
     
     
114. MIJDERWIJK HJ, Nieboer D, Incekara F, Berger K, et al
     Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma.
     J Neurosurg. 2022 Jan 14:1-10. doi: 10.3171/2021.10.JNS211261.
     PubMed     Abstract available
     
     
     
115. AL-HOLOU WN, Suki D, Hodges TR, Everson RG, et al
     Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas.
     J Neurosurg. 2022 Jan 7:1-11. doi: 10.3171/2021.9.JNS21718.
     PubMed     Abstract available
     
     
     
116. BROWN DA, Goyal A, Richter KR, Haglin JM, et al
     Clinical utility of brain biopsy for presumed CNS relapse of systemic lymphoma.
     J Neurosurg. 2021;136:30-39.
     PubMed     Abstract available
     
     
     December 2021
117. YOO J, Yoon SJ, Kim KH, Jung IH, et al
     Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study.
     J Neurosurg. 2021 Dec 31:1-11. doi: 10.3171/2021.10.JNS211491.
     PubMed     Abstract available
     
     
     
118. BENJAMIN CG, Gurewitz J, Kavi A, Bernstein K, et al
     Survival and outcomes in patients with >/= 25 cumulative brain metastases treated with stereotactic radiosurgery.
     J Neurosurg. 2021 Dec 24:1-11. doi: 10.3171/2021.9.JNS21882.
     PubMed     Abstract available
     
     
     
119. CHIOU GY, Chiang CL, Yang HC, Shen CI, et al
     Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.
     J Neurosurg. 2021 Dec 17:1-8. doi: 10.3171/2021.9.JNS211373.
     PubMed     Abstract available
     
     
     
120. YOMO S, Yako T, Kitazawa K, Oguchi K, et al
     Staged radiosurgery alone versus postoperative cavity radiosurgery for patients with midsize-to-large brain metastases: a propensity score matching analysis.
     J Neurosurg. 2021 Dec 17:1-8. doi: 10.3171/2021.9.JNS211797.
     PubMed     Abstract available
     
     
     
121. SHIBAHARA I, Saito R, Kanamori M, Sonoda Y, et al
     Role of the parietooccipital fissure and its implications in the pathophysiology of posterior medial temporal gliomas.
     J Neurosurg. 2021 Dec 14:1-10. doi: 10.3171/2021.7.JNS21990.
     PubMed     Abstract available
     
     
     
122. LONDON D, Patel DN, Donahue B, Navarro RE, et al
     The incidence and predictors of new brain metastases in patients with non-small cell lung cancer following discontinuation of systemic therapy.
     J Neurosurg. 2021 Dec 10:1-11. doi: 10.3171/2021.9.JNS212150.
     PubMed     Abstract available
     
     
     
123. GADOT R, Khan AB, Patel R, Goethe E, et al
     Predictors of postoperative seizure outcome in supratentorial meningioma.
     J Neurosurg. 2021 Dec 10:1-10. doi: 10.3171/2021.9.JNS211738.
     PubMed     Abstract available
     
     
     November 2021
124. MORSHED RA, Lee AT, Wang EJ, Young JS, et al
     Functional outcomes after resection of middle frontal gyrus diffuse gliomas.
     J Neurosurg. 2021 Nov 19:1-8. doi: 10.3171/2021.8.JNS211624.
     PubMed     Abstract available
     
     
     
125. RAMOS-FRESNEDO A, Domingo RA, Sanchez-Garavito JE, Perez-Vega C, et al
     The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience.
     J Neurosurg. 2021 Nov 19:1-9. doi: 10.3171/2021.8.JNS211252.
     PubMed     Abstract available
     
     
     
126. GOYAL A, Zreik J, Brown DA, Kerezoudis P, et al
     Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States.
     J Neurosurg. 2021 Nov 12:1-10. doi: 10.3171/2021.7.JNS211307.
     PubMed     Abstract available
     
     
     
127. BUNEVICIUS A, Pikis S, Kondziolka D, Patel DN, et al
     Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
     J Neurosurg. 2021 Nov 5:1-9. doi: 10.3171/2021.7.JNS211277.
     PubMed     Abstract available
     
     
     
128. MATHON B, Amelot A
     Letter to the Editor. The place of brain biopsy in patients with presumed CNS relapse of systemic lymphoma.
     J Neurosurg. 2021;136:933-934.
     PubMed    
     
     
     October 2021
129. AVERY MB, Mallari RJ, Barkhoudarian G, Kelly DF, et al
     Supraorbital and mini-pterional keyhole craniotomies for brain tumors: a clinical and anatomical comparison of indications and outcomes in 204 cases.
     J Neurosurg. 2021 Oct 29:1-11. doi: 10.3171/2021.6.JNS21759.
     PubMed     Abstract available
     
     
     
130. TRIPATHI S, Vivas-Buitrago T, Domingo RA, Biase G, et al
     IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model.
     J Neurosurg. 2021 Oct 29:1-9. doi: 10.3171/2021.6.JNS21925.
     PubMed     Abstract available
     
     
     
131. JUNGER ST, Reinecke D, Meissner AK, Goldbrunner R, et al
     Resection of symptomatic non-small cell lung cancer brain metastasis in the setting of multiple brain metastases.
     J Neurosurg. 2021 Oct 29:1-7. doi: 10.3171/2021.7.JNS211172.
     PubMed     Abstract available
     
     
     
132. WADIURA LI, Reichert D, Sperl V, Lang A, et al
     Influence of dexamethasone on visible 5-ALA fluorescence and quantitative protoporphyrin IX accumulation measured by fluorescence lifetime imaging in glioblastomas: is pretreatment obligatory before fluorescence-guided surgery?
     J Neurosurg. 2021 Oct 22:1-9. doi: 10.3171/2021.6.JNS21940.
     PubMed     Abstract available
     
     
     
133. KHALAFALLAH AM, Rakovec M, Burapachaisri K, Fung S, et al
     The Suprasellar Meningioma Patient-Reported Outcome Survey: a disease-specific patient-reported outcome measure for resection of suprasellar meningioma.
     J Neurosurg. 2021;:9.
     PubMed     Abstract available
     
     
     
134. GODIL SS, Tosi U, Gerges M, Garton ALA, et al
     Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy.
     J Neurosurg. 2021 Oct 15:1-9. doi: 10.3171/2021.5.JNS202011.
     PubMed     Abstract available
     
     
     
135. MOMIN AA, Soni P, Shao J, Nowacki AS, et al
     Adjuvant radiation versus observation with salvage radiation after gross-total resection of WHO grade II meningiomas: a propensity score-adjusted analysis.
     J Neurosurg. 2021 Oct 8:1-8. doi: 10.3171/2021.4.JNS21559.
     PubMed     Abstract available
     
     
     
136. SCHUPPER AJ, Baron RB, Cheung W, Rodriguez J, et al
     5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
     J Neurosurg. 2021 Oct 8:1-10. doi: 10.3171/2021.5.JNS21310.
     PubMed     Abstract available
     
     
     
137. POPADIC B, Scheichel F, Pinggera D, Weber M, et al
     The meningioma surface factor: a novel approach to quantify shape irregularity on preoperative imaging and its correlation with WHO grade.
     J Neurosurg. 2021 Oct 8:1-7. doi: 10.3171/2021.5.JNS204223.
     PubMed     Abstract available
     
     
     
138. DUFFAU H
     Introducing the concept of brain metaplasticity in glioma: how to reorient the pattern of neural reconfiguration to optimize the therapeutic strategy.
     J Neurosurg. 2021 Oct 8:1-5. doi: 10.3171/2021.5.JNS211214.
     PubMed    
     
     
     
139. YOUNG JS, Gogos AJ, Aabedi AA, Morshed RA, et al
     Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract.
     J Neurosurg. 2021 Oct 1:1-7. doi: 10.3171/2021.4.JNS21187.
     PubMed     Abstract available
     
     
     
140. FISHER FL, Zamanipoor Najafabadi AH, van der Meer PB, Boele FW, et al
     Long-term health-related quality of life and neurocognitive functioning after treatment in skull base meningioma patients.
     J Neurosurg. 2021 Oct 1:1-13. doi: 10.3171/2021.4.JNS203891.
     PubMed     Abstract available
     
     
     September 2021
141. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
     Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas within or close to motor-related areas: validation of utility for predicting motor function.
     J Neurosurg. 2021 Sep 24:1-10. doi: 10.3171/2021.3.JNS21374.
     PubMed     Abstract available
     
     
     
142. MEDIKONDA R, Patel K, Jackson C, Saleh L, et al
     The safety and efficacy of dexamethasone in the perioperative management of glioma patients.
     J Neurosurg. 2021 Sep 24:1-8. doi: 10.3171/2021.4.JNS204127.
     PubMed     Abstract available
     
     
     
143. ASUZU DT, Bunevicius A, Kormath Anand R, Suleiman M, et al
     Clinical and radiologic outcomes after stereotactic radiosurgery for meningiomas in direct contact with the optic apparatus: an international multicenter study.
     J Neurosurg. 2021 Sep 24:1-7. doi: 10.3171/2021.3.JNS21328.
     PubMed     Abstract available
     
     
     
144. HAMDAN N, Duffau H
     Extending the multistage surgical strategy for recurrent initially low-grade gliomas: functional and oncological outcomes in 31 consecutive patients who underwent a third resection under awake mapping.
     J Neurosurg. 2021 Sep 10:1-10. doi: 10.3171/2021.3.JNS21264.
     PubMed     Abstract available
     
     
     
145. CARNEVALE JA, Imber BS, Winston GM, Goldberg JL, et al
     Risk of tract recurrence with stereotactic biopsy of brain metastases: an 18-year cancer center experience.
     J Neurosurg. 2021 Sep 10:1-7. doi: 10.3171/2021.3.JNS204347.
     PubMed     Abstract available
     
     
     August 2021
146. SHIMIZU Y, Gumin J, Gao F, Hossain A, et al
     Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
     J Neurosurg. 2021 Aug 27:1-11. doi: 10.3171/2021.3.JNS203045.
     PubMed     Abstract available
     
     
     
147. MORSHED RA, Jiam NT, Wang EJ, Magill ST, et al
     Posterior petrous face meningiomas presenting with Meniere's-like syndrome: a case series and review of the literature.
     J Neurosurg. 2021 Aug 27:1-8. doi: 10.3171/2021.2.JNS203259.
     PubMed     Abstract available
     
     
     
148. BENJAMIN CG, Schnurman Z, Ashayeri K, Kazi E, et al
     Volumetric growth rates of untreated cavernous sinus meningiomas.
     J Neurosurg. 2021 Aug 20:1-8. doi: 10.3171/2021.2.JNS203485.
     PubMed     Abstract available
     
     
     
149. MEDIKONDA R, Choi J, Pant A, Saleh L, et al
     Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
     J Neurosurg. 2021 Aug 13:1-10. doi: 10.3171/2021.1.JNS202482.
     PubMed     Abstract available
     
     
     
150. SPINA A, Boari N, Mortini P
     Letter to the Editor. Management of hyperostotic spheno-orbital meningiomas.
     J Neurosurg. 2021 Aug 13:1-2. doi: 10.3171/2021.4.JNS21952.
     PubMed    
     
     
     
151. MICKO A, Agam MS, Brunswick A, Strickland BA, et al
     Treatment strategies for giant pituitary adenomas in the era of endoscopic transsphenoidal surgery: a multicenter series.
     J Neurosurg. 2021 Aug 13:1-10. doi: 10.3171/2021.1.JNS203982.
     PubMed     Abstract available
     
     
     
152. CHUANG JM, Hueng DY
     Letter to the Editor. Treatment of MGMT-positive glioblastoma.
     J Neurosurg. 2021 Aug 6:1. doi: 10.3171/2021.3.JNS21571.
     PubMed    
     
     
     
153. ROMERO-GARCIA R, Suckling J, Owen M, Assem M, et al
     Memory recovery in relation to default mode network impairment and neurite density during brain tumor treatment.
     J Neurosurg. 2021 Aug 6:1-11. doi: 10.3171/2021.1.JNS203959.
     PubMed     Abstract available
     
     
     July 2021
154. AMMANUEL SG, Almeida NC, Kurteff G, Kakaizada S, et al
     Correlation of natural language assessment results with health-related quality of life in adult glioma patients.
     J Neurosurg. 2021 Jul 30:1-7. doi: 10.3171/2021.1.JNS203387.
     PubMed     Abstract available
     
     
     
155. LAD M, Gupta R, Raman A, Parikh N, et al
     Trends in physician reimbursements and procedural volumes for radiosurgery versus open surgery in brain tumor care: an analysis of Medicare data from 2009 to 2018.
     J Neurosurg. 2021 Jul 30:1-12. doi: 10.3171/2020.11.JNS202284.
     PubMed     Abstract available
     
     
     
156. SILVA LL, Tuncer MS, Vajkoczy P, Picht T, et al
     Distinct approaches to language pathway tractography: comparison of anatomy-based, repetitive navigated transcranial magnetic stimulation (rTMS)-based, and rTMS-enhanced diffusion tensor imaging-fiber tracking.
     J Neurosurg. 2021 Jul 30:1-12. doi: 10.3171/2020.12.JNS204028.
     PubMed     Abstract available
     
     
     
157. HAMIDI N, Karmur B, Sperrazza S, Alexieva J, et al
     Guidelines for optimal utilization of social media for brain tumor stakeholders.
     J Neurosurg. 2021 Jul 23:1-8. doi: 10.3171/2020.11.JNS203226.
     PubMed     Abstract available
     
     
     
158. ULGEN E, Aras FK, Cosgun E, Ersen-Danyeli A, et al
     Correlation of anatomical involvement patterns of insular gliomas with subnetworks of the limbic system.
     J Neurosurg. 2021 Jul 23:1-12. doi: 10.3171/2020.12.JNS203652.
     PubMed     Abstract available
     
     
     
159. ASANO K, Hasegawa S, Matsuzaka M, Ohkuma H, et al
     Brain tumor-related epilepsy and risk factors for metastatic brain tumors: analysis of 601 consecutive cases providing real-world data.
     J Neurosurg. 2021 Jul 16:1-12. doi: 10.3171/2020.11.JNS202873.
     PubMed     Abstract available
     
     
     
160. NEMAN J, Franklin M, Madaj Z, Deshpande K, et al
     Use of predictive spatial modeling to reveal that primary cancers have distinct central nervous system topography patterns of brain metastasis.
     J Neurosurg. 2021 Jul 16:1-9. doi: 10.3171/2021.1.JNS203536.
     PubMed     Abstract available
     
     
     
161. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
     On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
     J Neurosurg. 2021 Jul 9:1-11. doi: 10.3171/2020.11.JNS202897.
     PubMed     Abstract available
     
     
     
162. LI L, Fang S, Li G, Zhang K, et al
     Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
     J Neurosurg. 2021 Jul 9:1-9. doi: 10.3171/2020.12.JNS203351.
     PubMed     Abstract available
     
     
     
163. CHAN AY, Choi EH, Oh MY, Vadera S, et al
     Elective versus nonelective brain tumor resections: a 5-year propensity score matching cost comparison analysis.
     J Neurosurg. 2021 Jul 9:1-5. doi: 10.3171/2020.12.JNS203401.
     PubMed     Abstract available
     
     
     June 2021
164. ROSSI M, Puglisi G, Conti Nibali M, Vigano L, et al
     Asleep or awake motor mapping for resection of perirolandic glioma in the nondominant hemisphere? Development and validation of a multimodal score to tailor the surgical strategy.
     J Neurosurg. 2021 Jun 18:1-14. doi: 10.3171/2020.11.JNS202715.
     PubMed     Abstract available
     
     
     
165. MOHAMMED N, Hung YC, Xu Z, Chytka T, et al
     Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery.
     J Neurosurg. 2021 Jun 18:1-6. doi: 10.3171/2020.12.JNS202814.
     PubMed     Abstract available
     
     
     
166. KANEKO S, Suero Molina E, Sporns P, Schipmann S, et al
     Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
     J Neurosurg. 2021 Jun 18:1-7. doi: 10.3171/2020.10.JNS202881.
     PubMed     Abstract available
     
     
     
167. SHAH PP, Franke JL, Medikonda R, Jackson CM, et al
     Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
     J Neurosurg. 2021 Jun 4:1-11. doi: 10.3171/2020.10.JNS201787.
     PubMed     Abstract available
     
     
     
168. DELLA PEPA GM, D'Alessandris QG, Burattini B, Quaranta D, et al
     Letter to the Editor. Exploring cognitive functions in low-grade glioma surgery.
     J Neurosurg. 2021 Jun 4:1-2. doi: 10.3171/2021.2.JNS21186.
     PubMed    
     
     
     
169. VIVAS-BUITRAGO T, Domingo RA, Tripathi S, De Biase G, et al
     Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
     J Neurosurg. 2021 Jun 4:1-8. doi: 10.3171/2020.10.JNS203366.
     PubMed     Abstract available
     
     
     May 2021
170. ROTH O'BRIEN DA, Kaye SM, Poppas PJ, Mahase SS, et al
     Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis.
     J Neurosurg. 2021 May 28:1-11. doi: 10.3171/2020.10.JNS201934.
     PubMed     Abstract available
     
     
     
171. BABA A, Saha A, McCradden MD, Boparai K, et al
     Development and validation of a patient-centered, meningioma-specific quality-of-life questionnaire.
     J Neurosurg. 2021 May 14:1-10. doi: 10.3171/2020.11.JNS201761.
     PubMed     Abstract available
     
     
     
172. QIAO N, Yang X, Li C, Ma G, et al
     The predictive value of intraoperative visual evoked potential for visual outcome after extended endoscopic endonasal surgery for adult craniopharyngioma.
     J Neurosurg. 2021 May 7:1-11. doi: 10.3171/2020.10.JNS202779.
     PubMed     Abstract available
     
     
     March 2021
173. FAN J, Liu Y, Pan J, Peng Y, et al
     Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients.
     J Neurosurg. 2021 Mar 5:1-12. doi: 10.3171/2020.7.JNS20257.
     PubMed     Abstract available
     
     
     
174. MAGILL ST, Jane JA, Prevedello DM
     Editorial. Craniopharyngioma classification.
     J Neurosurg. 2021 Mar 5:1-3. doi: 10.3171/2020.8.JNS202666.
     PubMed    
     
     
     
175. FONSECA A, Solano P, Ramaswamy V, Tabori U, et al
     Ventricular size determination and management of ventriculomegaly and hydrocephalus in patients with diffuse intrinsic pontine glioma: an institutional experience.
     J Neurosurg. 2021 Mar 5:1-7. doi: 10.3171/2020.10.JNS203257.
     PubMed     Abstract available
     
     
     
176. TENG CW, Cho SS, Singh Y, De Ravin E, et al
     Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgery.
     J Neurosurg. 2021 Mar 2:1-10. doi: 10.3171/2020.8.JNS201810.
     PubMed     Abstract available
     
     
     February 2021
177. MORISAKO H, Ohata H, Shinde B, Nagahama A, et al
     Minimal anterior and posterior combined transpetrosal approach for large petroclival meningiomas.
     J Neurosurg. 2021 Feb 19:1-10. doi: 10.3171/2020.8.JNS202060.
     PubMed     Abstract available
     
     
     
178. RAPOPORT BI, McDermott MW, Schwartz TH
     Letter to the Editor. Time to move beyond the Simpson scale in meningioma surgery.
     J Neurosurg. 2021 Feb 19:1-2. doi: 10.3171/2020.12.JNS204213.
     PubMed    
     
     
     January 2021
179. MAGILL ST, Nguyen MP, Aghi MK, Theodosopoulos PV, et al
     Postoperative diffusion-weighted imaging and neurological outcome after convexity meningioma resection.
     J Neurosurg. 2021 Jan 29:1-8. doi: 10.3171/2020.8.JNS193537.
     PubMed     Abstract available
     
     
     
180. MOTOMURA K, Chalise L, Shimizu H, Yamaguchi J, et al
     Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery.
     J Neurosurg. 2021 Jan 22:1-10. doi: 10.3171/2020.8.JNS201400.
     PubMed     Abstract available
     
     
     
181. YOUNG JS, Gogos AJ, Pereira MP, Morshed RA, et al
     Effects of ventricular entry on patient outcome during glioblastoma resection.
     J Neurosurg. 2021 Jan 8:1-9. doi: 10.3171/2020.7.JNS201362.
     PubMed     Abstract available
     
     
     
182. BUNEVICIUS A, Suleiman M, Patel S, Martinez Alvarez R, et al
     Stereotactic radiosurgery for treatment of radiation-induced meningiomas: a multiinstitutional study.
     J Neurosurg. 2021 Jan 1:1-9. doi: 10.3171/2020.7.JNS202064.
     PubMed     Abstract available
     
     
     December 2020
183. STOGBAUER L, Thomas C, Wagner A, Warneke N, et al
     Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT.
     J Neurosurg. 2020 Dec 11:1-10. doi: 10.3171/2020.7.JNS193097.
     PubMed     Abstract available
     
     
     
184. KENNEDY WR, DeWees TA, Acharya S, Mahmood M, et al
     Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery.
     J Neurosurg. 2020 Dec 11:1-7. doi: 10.3171/2020.7.JNS192210.
     PubMed     Abstract available
     
     
     
185. GUPTE TP, Li C, Jin L, Yalcin K, et al
     Clinical and genomic factors associated with seizures in meningiomas.
     J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201042.
     PubMed     Abstract available
     
     
     
186. NG S, Herbet G, Lemaitre AL, Cochereau J, et al
     Neuropsychological assessments before and after awake surgery for incidental low-grade gliomas.
     J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201507.
     PubMed     Abstract available
     
     
     November 2020
187. GOGOS AJ
     Erratum. Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
     J Neurosurg. 2020 Nov 27:1. doi: 10.3171/2020.10.JNS193434.
     PubMed    
     
     
     
188. YOO DH, Sohn CH, Cho YD, Kang HS, et al
     Superselective pseudocontinuous arterial spin labeling in patients with meningioma: utility in prediction of feeding arteries and preoperative embolization feasibility.
     J Neurosurg. 2020 Nov 13:1-7. doi: 10.3171/2020.7.JNS201915.
     PubMed     Abstract available
     
     
     
189. MIYOSHI K, Wada T, Uwano I, Sasaki M, et al
     Predicting the consistency of intracranial meningiomas using apparent diffusion coefficient maps derived from preoperative diffusion-weighted imaging.
     J Neurosurg. 2020 Nov 13:1-8. doi: 10.3171/2020.6.JNS20740.
     PubMed     Abstract available
     
     
     October 2020
190. PRZYBYLOWSKI CJ, Hendricks BK, Frisoli FA, Zhao X, et al
     Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience.
     J Neurosurg. 2020 Oct 23:1-9. doi: 10.3171/2020.6.JNS20374.
     PubMed     Abstract available
     
     
     
191. CHICOINE MR, Yahanda AT, Dacey RG
     A tribute to the late Professor Donald Simpson, Australian neurosurgeon and namesake of the Simpson grading system for meningioma extent of resection.
     J Neurosurg. 2020 Oct 23:1-7. doi: 10.3171/2020.6.JNS201331.
     PubMed     Abstract available
     
     
     
192. SHAH AS, Sylvester PT, Yahanda AT, Vellimana AK, et al
     Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.
     J Neurosurg. 2020 Oct 9:1-10. doi: 10.3171/2020.6.JNS19287.
     PubMed     Abstract available
     
     
     
193. SELLIER A, Moritz-Gasser S, Lemaitre AL, Herbet G, et al
     Presence of a translator in the operating theater for awake mapping in foreign patients with low-grade glioma: a surgical experience based on 18 different native languages.
     J Neurosurg. 2020 Oct 9:1-9. doi: 10.3171/2020.6.JNS201071.
     PubMed     Abstract available
     
     
     
194. GOGOS AJ, Young JS, Pereira MP, Morshed RA, et al
     Surgical management of incidentally discovered low-grade gliomas.
     J Neurosurg. 2020 Oct 2:1-8. doi: 10.3171/2020.6.JNS201296.
     PubMed     Abstract available
     
     
     
195. LIVERMORE LJ, Isabelle M, Bell IM, Edgar O, et al
     Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced fluorescence-guided surgery.
     J Neurosurg. 2020 Oct 2:1-11. doi: 10.3171/2020.5.JNS20376.
     PubMed     Abstract available
     
     
     June 2020
196. TAKAMI H, Khoshnood N, Bernstein M
     Preoperative factors associated with adverse events during awake craniotomy: analysis of 609 consecutive cases.
     J Neurosurg. 2020 Jun 26:1-9. doi: 10.3171/2020.4.JNS20378.
     PubMed     Abstract available
     
     
     May 2020
197. YOUNG JS, Chan AK, Viner JA, Sankaran S, et al
     A Safe Transitions Pathway for post-craniotomy neurological surgery patients: high-value care that bypasses the intensive care unit.
     J Neurosurg. 2020 May 29:1-6. doi: 10.3171/2020.3.JNS192133.
     PubMed     Abstract available
     
     
     April 2020
198. CARRION-PENAGOS J, Zeineddine HA, Polster SP, Girard R, et al
     Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
     J Neurosurg. 2020 Apr 3:1-8. doi: 10.3171/2020.1.JNS193479.
     PubMed     Abstract available
     
     
     March 2020
199. LOHMANN S, Brix T, Varghese J, Warneke N, et al
     Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors.
     J Neurosurg. 2020 Mar 20:1-11. doi: 10.3171/2020.1.JNS193186.
     PubMed     Abstract available
     
     
     February 2020
200. RUTLAND JW, Loewenstern J, Ranti D, Tsankova NM, et al
     Analysis of 7-tesla diffusion-weighted imaging in the prediction of pituitary macroadenoma consistency.
     J Neurosurg. 2020 Feb 28:1-9. doi: 10.3171/2019.12.JNS192940.
     PubMed     Abstract available
     
     
     
201. ALHILALI LM, Little AS, Yuen KCJ, Lee J, et al
     Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery.
     J Neurosurg. 2020 Feb 7:1-10. doi: 10.3171/2019.11.JNS191845.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: